Skip to main content
logo
Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)
China flag China · Delayed Price · Currency is CNY
7.53
-0.20 (-2.59%)
At close: Apr 17, 2026

SHA:688189 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
2,1071,7842,5883,3834,9316,845
Market Cap Growth
11.92%-31.04%-23.51%-31.39%-27.96%-
Enterprise Value
1,7621,4352,3703,4024,8006,140
Last Close Price
7.736.549.4312.3317.9724.75
PE Ratio
-----53.49
Forward PE
-15.1615.1615.1615.16-
PS Ratio
22.106.783.594.846.636.65
PB Ratio
2.632.032.012.613.544.23
P/TBV Ratio
2.872.252.222.904.044.56
P/FCF Ratio
--14.08---
P/OCF Ratio
45.301280.4612.02---
EV/Sales Ratio
18.485.453.294.876.465.97
EV/EBITDA Ratio
--58.91--39.26
EV/EBIT Ratio
--546.78--50.34
EV/FCF Ratio
-38.71-12.90---
Debt / Equity Ratio
0.190.250.250.420.340.21
Debt / EBITDA Ratio
--7.81--2.21
Debt / FCF Ratio
--1.77---
Net Debt / Equity Ratio
-0.35-0.31-0.26-0.13-0.18-0.38
Net Debt / EBITDA Ratio
0.850.84-8.485.161.43-3.94
Net Debt / FCF Ratio
6.144.75-1.860.841.451.94
Asset Turnover
0.080.180.390.340.350.71
Inventory Turnover
1.512.834.242.671.942.48
Quick Ratio
2.182.052.882.252.274.23
Current Ratio
2.502.292.972.312.394.49
Return on Equity (ROE)
-40.51%-36.72%-0.84%-7.26%-12.09%13.59%
Return on Assets (ROA)
-19.06%-15.29%0.15%-2.44%-6.38%5.25%
Return on Invested Capital (ROIC)
-68.97%-46.39%0.42%-7.03%-20.19%15.77%
Return on Capital Employed (ROCE)
-45.60%-40.80%0.30%-6.10%-14.80%7.20%
Earnings Yield
-17.48%-20.00%-0.42%-2.33%-3.28%1.87%
FCF Yield
-2.16%-3.20%7.10%-5.94%-3.58%-4.65%
Dividend Yield
-----0.60%
Payout Ratio
-----10.55%
Buyback Yield / Dilution
0.65%0.03%-0.03%0.01%-6.66%-25.02%
Total Shareholder Return
0.65%0.03%-0.03%0.01%-6.66%-24.42%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.